Sarah Ford | April 18, 2014
Researcher Examines Impact of Extra Chromosome on Acute Myeloid Leukemia
David Gordon, MD, PhD at Dana Farber Cancer Institute is a CureSearch Young Investigator examining the impact of trisomy 8 on acute myeloid leukemia (AML). Of the 500 children diagnosed with AML each year, between 10-20% of an extra chromosome 8, called trisomy 8.
Dr. Gordon suspects that trisomy 8 contributes to the creation of cancerous cells because certain genes are expressed when an abnormal number of chromosomes are present. Using three cell lines he previously developed, Dr. Gordon spent the first year of his CureSearch grant screening the cell lines for new AML target genes and investigating the impact of trisomy 8 in blood cell development.
In the coming year, Dr. Gordon will explore how these genes, and their interaction with trisomy 8, lead to the development of AML.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Celebrating Juneteenth and Continuing to Work in Solidarity for Racial Justice, Equality, and Equity
June 19 — also known as Juneteenth, or the nation’s second Independence Day — commemorates the end of slavery in Texas, and therefore the nation,…
Read Article
LGBTQIA+ Pride Month 2024
In honor of the 1969 Stonewall Uprising in Manhattan – considered the tipping point for the Gay Liberation Movement in the United States – each…
Read Article
Men’s Health Month
June is Men’s Health Month, a time to focus on the unique health challenges faced by men and to encourage them to prioritize their physical…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
